Posts Tagged ‘biologics’

Advancing Innovation in Pharmaceutical and Biologics Manufacturing

Posted in Life Sciences, Regulatory Compliance on Monday, August 13th, 2018. No comments yet
Tags: , , , , ,

In a U.S. Food and Drug Administration’s FDA Voice blog post, FDA Budget Matters: Investing in Advanced Domestic Manufacturing, FDA Commissioner Dr. Scott Gottlieb opened noting: Advanced manufacturing, which includes various technologies, such as continuous manufacturing and 3D printing, holds great promise for improving the American market for drugs and biologicals. Emerson’s Ron Rossbach shared […]

Optimizing Media Flow in Biologics Manufacturing

Posted in Life Sciences on Monday, June 11th, 2018. No comments yet
Tags: , , ,

Author: Emily Anderson Flexible facilities are a growing trend in the biopharmaceutical manufacturing industry. Manufacturers increasingly look to produce multiple products and maximize production time. To meet these requirements, an automation strategy must maximize the flexibility of the process equipment. The preparation, storage, and distribution of media often requires real-time flowpath selection and bumpless transfer […]

Bridging Islands of Automation

Posted in Life Sciences, Operations Management on Thursday, December 5th, 2013. 2 comments so far
Tags: , , , , , , , , , ,

While integration technologies have helped bridge “islands of automation” over the years, some process manufacturers still have parts of their automated processes disconnected from the rest. Emerson’s Gary Mitchell, a senior industry consultant on the Life Sciences industry team, shares some recent experiences on bridging these islands. I’m spending a lot of my time recently […]